SphingoTec

Private

HennigsdorfHealthcare & Life Scienceshttps://www.sphingotec.eu/

Last Round

Series C

Aug 8, 2024

Total Funding Raised

$28.55M

Company Overview

SphingoTec is a diagnostics company that develops and markets innovative in vitro diagnostic (IVD) tests for novel and proprietary biomarkers for the diagnosis, prediction and monitoring of acute medical conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

biomarker assaysnovel biomarkersin-vitro diagnosticsIVDpoint-of-care diagnosticsPOC diagnosticsbiomarker out-licensingacute care diagnosticscritical care diagnosticspenKidsepsis diagnosticsacute kidney injurykidney function assessmentbio-ADMacute heart failureclinical trial supportNexus IB10endothelial function

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SphingoTec Comps

Public and private peers based on sector, stage, and business model.

SphingoTec comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SphingoTec Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series C	Aug 8, 2024
VC Round	Feb 21, 2024
Growth Equity	Oct 8, 2018

View all Funding Rounds

SphingoTec Investors

Notable investors and investment history

SphingoTec investors
Investor	Rounds
Think.Health	Series C
HBM Healthcare Investments	Series C, Growth Equity
NRW.Bank	Series C
Brandenburg Kapital	Series C
Wellington Partners	Series C, Growth Equity

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Aug 8, 2024
$5.55M round led by Think.Health.
Feb 21, 2024
Completed a VC Round fundraise.

View all signals

SphingoTec Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SphingoTec Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SphingoTec's valuation, stock price, and market status.

Firmographic Details

HeadquartersHennigsdorf

Year Founded2002

Last FundingAug 8, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.